Your browser doesn't support javascript.
loading
Neuropsychological changes in patients with substance use disorder after completion of a one month intensive outpatient treatment program.
McKowen, James W; Isenberg, Benjamin M; Carrellas, Nicholas W; Zulauf, Courtney A; Ward, Nalan E; Fried, Ronna S; Wilens, Timothy E.
Afiliação
  • McKowen JW; Addiction Recovery Management Service and West End Clinic, Massachusetts General Hospital, Boston, Massachusetts.
  • Isenberg BM; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
  • Carrellas NW; Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts.
  • Zulauf CA; Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts.
  • Ward NE; Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts.
  • Fried RS; Addiction Recovery Management Service and West End Clinic, Massachusetts General Hospital, Boston, Massachusetts.
  • Wilens TE; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Am J Addict ; 27(8): 632-638, 2018 12.
Article em En | MEDLINE | ID: mdl-30387896
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Data suggest individuals with substance use disorders (SUD) exhibit high rates of executive functioning (EF) impairment, and that EF level can predict treatment retention. The primary aim of the present study was to investigate if patients who completed a 1 month intensive outpatient program (IOP) for SUD demonstrated recovered EF.

METHODS:

Baseline and follow-up neurocognitive functioning was assessed by the Cambridge Neuropsychological Test Automated Battery (CANTAB) and the self-reported Behavior Rating Inventory of Executive Functioning (BRIEF-A) questionnaire.

RESULTS:

The final sample included 15 patients who completed the one month IOP and for whom data were available (53% male, aged 36 years ± 13.4). Despite exhibiting general improvements in EF and significant improvements in organization, subjects continued to manifest significant executive dysfunction as evaluated by self-report and computerized assessment. CONCLUSIONS AND SCIENTIFIC

SIGNIFICANCE:

Patients with SUD often manifest high levels of executive dysfunction upon entry into SUD treatment that, while improving minimally, appears to persist despite intensive outpatient treatment at 1 month. These persistent EF deficits may affect patient engagement and participation in treatment, thus necessitating SUD programs to assess and accommodate EF issues throughout treatment. (Am J Addict 2018;XX1-7).
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sintomas Comportamentais / Transtornos Relacionados ao Uso de Substâncias / Função Executiva Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Addict Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sintomas Comportamentais / Transtornos Relacionados ao Uso de Substâncias / Função Executiva Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Addict Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2018 Tipo de documento: Article